Skip to main content
MediWound Ltd. logo

MediWound Ltd. — Investor Relations & Filings

Ticker · MDWD ISIN · IL0011316309 LEI · 549300LJKCS74GRYKF90 US Manufacturing
Open in API
Filings indexed 370 across all filing types
Latest filing 2022-11-28 Regulatory Filings
Country IL Israel
Listing US MDWD

About MediWound Ltd.

https://www.mediwound.com/

MediWound Ltd. is a fully integrated biopharmaceutical company that develops, manufactures, and commercializes enzymatic therapeutics for non-surgical tissue repair. The company's core technology focuses on next-generation treatments that selectively remove eschar (non-viable tissue) from severe burns and chronic wounds while preserving healthy tissue. This approach is designed to accelerate healing, improve patient outcomes, and lower overall healthcare costs. Its primary commercial product is a topical biologic for the debridement of severe thermal burns. MediWound maintains a research and development pipeline aimed at expanding its enzymatic platform to address additional unmet medical needs in wound care.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings
2022-11-28 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) related to the resale of ordinary shares by selling shareholders. It details the securities being offered, the background of the warrants, the registration statement, and includes sections such as Risk Factors, Use of Proceeds, Description of Ordinary Shares, Selling Shareholders, and Plan of Distribution. The document is a registration prospectus for a securities offering, not a financial report, earnings release, or management discussion. It is a capital markets document related to financing activities and share issuance. Therefore, it fits best under the category Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a brief notice, but a full prospectus. Hence, the classification is CAP with high confidence.
2022-11-25 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a letter from MediWound Ltd. to the SEC requesting acceleration of the effective date of a Registration Statement on Form F-1. It references regulatory rules (Rule 460 and 461) and the Securities Act of 1933. The content is a formal request related to a filing process rather than the filing itself or a report containing financial data. The document length is short (1406 characters) and it does not contain financial statements or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and filings that do not fit other categories.
2022-11-22 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement. Due to the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but without readable content, it cannot be classified as a financial or other specific report type.
2022-11-16 English
6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, MediWound Ltd., which includes a press release about third quarter 2022 financial results and an un-audited condensed consolidated interim financial statement as of September 30, 2022. The presence of interim financial statements with substantive financial data indicates this is an Interim / Quarterly Report. The document length is 3145 characters, which is relatively short but contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-11-15 English
6-K/A
Regulatory Filings Classification · 100% confidence The document is a Form 6-K/A, which is an amendment to a previously filed Form 6-K. Form 6-K is a report of a foreign private issuer submitted to the SEC to provide updates or additional information between annual reports (Form 20-F). The document is short (2359 characters) and primarily amends incorporation by reference language related to prior filings. It does not contain substantive financial data or detailed report content itself. Therefore, it is a regulatory filing updating prior disclosures rather than a full financial report or other specific filing type. According to the rules, such documents are best classified as Regulatory Filings (RNS).
2022-11-14 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.